Latest News

DexCom (DXCM) just rolled out Dexcom Academy, a tailored learning platform for healthcare professionals that could quietly reshape how its continuous glucose monitors are used day to day and, in turn, how investors view the stock. See our latest analysis for DexCom. That launch lands at an interesting moment, with the share price at $67.55 and a 30 day share price return of 23.18% suggesting short term momentum is rebuilding, even as the 1 year total shareholder return of negative 16.06%...

Sandoz Group (SWX:SDZ) just kicked off a major European rollout of its Wyost and Jubbonti denosumab biosimilars, opening fresh exposure to a multibillion dollar cancer bone disease and osteoporosis market. See our latest analysis for Sandoz Group. The denosumab rollout lands at a strong moment for Sandoz, with a 30 day share price return of 9.77% and a 90 day share price return of 22.49% helping drive a 1 year total shareholder return of 60.6%. This suggests momentum is building as investors...

On December 8, 2025, The Macerich Company reported at the Nareit REITWorld conference in Dallas that it had achieved record leasing activity of 3.2 million square feet by the third quarter and completed US$1.20 billion in mall asset sales, alongside opening more than 300 new stores including luxury and international brands. This combination of robust leasing performance and sizable asset sales highlights how Macerich is both filling space with higher-quality tenants and actively reshaping...

TotalEnergies (ENXTPA:TTE) has been grinding higher over the past month, outpacing many European energy peers as investors reassess its mix of traditional oil assets and growing renewables exposure, with the stock still trading at a moderate valuation. See our latest analysis for TotalEnergies. At around $55.82, the recent pullback after a steady 30 day share price return of 3.29% sits against a solid 10.89% 1 year total shareholder return, suggesting momentum is cooling slightly rather than...

Earlier this month, KBRA assigned preliminary ratings to 10 classes of mortgage-backed notes from New Residential Mortgage Loan Trust 2025-NQM7, a non-prime RMBS deal sponsored by Rithm Capital and backed mainly by loans originated by NewRez LLC and Champions Funding, LLC. This latest non-prime securitization highlights Rithm’s ongoing use of capital markets to fund and recycle mortgage risk across its broader real estate credit platform. We’ll now consider how Rithm’s new non-prime RMBS...

If you are wondering whether WisdomTree is still a smart buy at around $11.69, you are not alone. This stock sits at the crossroads of growth, income, and structural change in asset management. After a 4.7% gain over the last week and a strong 15.6% return year to date, the stock has cooled slightly in the last month with a -0.3% move, while still sitting on hefty 3 year and 5 year gains of 125.2% and 162.2% respectively. Those moves have come as WisdomTree has leaned further into thematic...

BioArctic’s partner Eisai has announced that Alzheimer’s drug Leqembi (lecanemab) has been added to China’s National Healthcare Security Administration “Commercial Insurance Innovative Drug List,” expanding access to early Alzheimer’s treatment in a key market following its June 2024 launch there. This move materially enhances the commercial potential of Leqembi in China, which could be important for BioArctic given its role in the drug’s development and its ongoing commercialization...

Hasbro recently reported quarterly revenues of US$1.39 billion, an 8.3% year-on-year increase that surpassed analyst expectations by 3.2%, underscoring the current strength of its core brands and Playing to Win plan. These results were the strongest within its peer group for both revenue growth and analyst estimate beats, highlighting how Hasbro’s operational execution is currently outpacing many competitors in the sector. We’ll now examine how Hasbro’s recent earnings beat, reflecting...

The board of Keikyu Corporation ( TSE:9006 ) has announced that it will pay a dividend of ¥23.00 per share on the 30th...

With a price-to-sales (or "P/S") ratio of 3.3x Raiz Invest Limited ( ASX:RZI ) may be sending very bullish signals at...

China Saftower International Holding Group Limited's ( HKG:8623 ) price-to-sales (or "P/S") ratio of 0.1x may look like...

It is hard to get excited after looking at Ausupreme International Holdings' (HKG:2031) recent performance, when its...

The last three months have been tough on IVD Medical Holding Limited ( HKG:1931 ) shareholders, who have seen the share...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

There wouldn't be many who think Ying Hai Group Holdings Company Limited's ( HKG:8668 ) price-to-sales (or "P/S") ratio...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...

While Red Star Macalline Group Corporation Ltd. ( HKG:1528 ) might not have the largest market cap around , it saw a...

When you see that almost half of the companies in the Electrical industry in Hong Kong have price-to-sales ratios (or...

It's not a stretch to say that Hanwha Solutions Corporation's ( KRX:009830 ) price-to-sales (or "P/S") ratio of 0.3x...

China Foods' (HKG:506) stock up by 4.3% over the past week. Since the market usually pay for a company’s long-term...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

With a median price-to-sales (or "P/S") ratio of close to 0.9x in the Hospitality industry in Japan, you could be...

The art and science of stock market investing requires a tolerance for losing money on some of the shares you buy. But...

There wouldn't be many who think FUJIFILM Holdings Corporation's ( TSE:4901 ) price-to-earnings (or "P/E") ratio of 15x...